Sanjay Basu, John S Yudkin, Sylvia Kehlenbrink, Justine I Davies, Sarah H Wild, Kasia J Lipska, Jeremy B Sussman, David Beran. Lancet Diabetes Endocrinol 2019
Times Cited: 68
Times Cited: 68
Times Cited
Times Co-cited
Similarity
Constraints and challenges in access to insulin: a global perspective.
David Beran, Margaret Ewen, Richard Laing. Lancet Diabetes Endocrinol 2016
David Beran, Margaret Ewen, Richard Laing. Lancet Diabetes Endocrinol 2016
14
A perspective on global access to insulin: a descriptive study of the market, trade flows and prices.
D Beran, R O Laing, W Kaplan, R Knox, A Sharma, V J Wirtz, J Frye, M Ewen. Diabet Med 2019
D Beran, R O Laing, W Kaplan, R Knox, A Sharma, V J Wirtz, J Frye, M Ewen. Diabet Med 2019
50
A global perspective on the issue of access to insulin.
David Beran, Maria Lazo-Porras, Camille M Mba, Jean Claude Mbanya. Diabetologia 2021
David Beran, Maria Lazo-Porras, Camille M Mba, Jean Claude Mbanya. Diabetologia 2021
26
Insulin prices, availability and affordability in 13 low-income and middle-income countries.
Margaret Ewen, Huibert-Jan Joosse, David Beran, Richard Laing. BMJ Glob Health 2019
Margaret Ewen, Huibert-Jan Joosse, David Beran, Richard Laing. BMJ Glob Health 2019
16
Diabetes in sub-Saharan Africa: from clinical care to health policy.
Rifat Atun, Justine I Davies, Edwin A M Gale, Till Bärnighausen, David Beran, Andre Pascal Kengne, Naomi S Levitt, Florence W Mangugu, Moffat J Nyirenda, Graham D Ogle,[...]. Lancet Diabetes Endocrinol 2017
Rifat Atun, Justine I Davies, Edwin A M Gale, Till Bärnighausen, David Beran, Andre Pascal Kengne, Naomi S Levitt, Florence W Mangugu, Moffat J Nyirenda, Graham D Ogle,[...]. Lancet Diabetes Endocrinol 2017
7
Production costs and potential prices for biosimilars of human insulin and insulin analogues.
Dzintars Gotham, Melissa J Barber, Andrew Hill. BMJ Glob Health 2018
Dzintars Gotham, Melissa J Barber, Andrew Hill. BMJ Glob Health 2018
20
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021.
. Diabetes Care 2021
. Diabetes Care 2021
7
Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.
Xinyang Hua, Natalie Carvalho, Michelle Tew, Elbert S Huang, William H Herman, Philip Clarke. JAMA 2016
Xinyang Hua, Natalie Carvalho, Michelle Tew, Elbert S Huang, William H Herman, Philip Clarke. JAMA 2016
5
Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.
Kasia J Lipska, Joseph S Ross, Holly K Van Houten, David Beran, John S Yudkin, Nilay D Shah. JAMA 2014
Kasia J Lipska, Joseph S Ross, Holly K Van Houten, David Beran, John S Yudkin, Nilay D Shah. JAMA 2014
6
Cost-Related Insulin Underuse Among Patients With Diabetes.
Darby Herkert, Pavithra Vijayakumar, Jing Luo, Jeremy I Schwartz, Tracy L Rabin, Eunice DeFilippo, Kasia J Lipska. JAMA Intern Med 2019
Darby Herkert, Pavithra Vijayakumar, Jing Luo, Jeremy I Schwartz, Tracy L Rabin, Eunice DeFilippo, Kasia J Lipska. JAMA Intern Med 2019
5
The role of biosimilar manufacturers in improving access to insulin globally.
Christophe Perrin, Margaret Ewen, David Beran. Lancet Diabetes Endocrinol 2017
Christophe Perrin, Margaret Ewen, David Beran. Lancet Diabetes Endocrinol 2017
40
The global intellectual property ecosystem for insulin and its public health implications: an observational study.
Warren A Kaplan, Reed F Beall. J Pharm Policy Pract 2016
Warren A Kaplan, Reed F Beall. J Pharm Policy Pract 2016
57
Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
Christian Bommer, Vera Sagalova, Esther Heesemann, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Justine Davies, Sebastian Vollmer. Diabetes Care 2018
Christian Bommer, Vera Sagalova, Esther Heesemann, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Justine Davies, Sebastian Vollmer. Diabetes Care 2018
5
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
5
Ever-Increasing Insulin-Requiring Patients Globally.
Satish K Garg, Amanda H Rewers, Halis Kaan Akturk. Diabetes Technol Ther 2018
Satish K Garg, Amanda H Rewers, Halis Kaan Akturk. Diabetes Technol Ther 2018
14
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5
How many people inject insulin? UK estimates from 1991 to 2010.
S E Holden, E A M Gale, S Jenkins-Jones, C J Currie. Diabetes Obes Metab 2014
S E Holden, E A M Gale, S Jenkins-Jones, C J Currie. Diabetes Obes Metab 2014
14
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Juliana C N Chan, Lee-Ling Lim, Nicholas J Wareham, Jonathan E Shaw, Trevor J Orchard, Ping Zhang, Eric S H Lau, Björn Eliasson, Alice P S Kong, Majid Ezzati,[...]. Lancet 2021
Juliana C N Chan, Lee-Ling Lim, Nicholas J Wareham, Jonathan E Shaw, Trevor J Orchard, Ping Zhang, Eric S H Lau, Björn Eliasson, Alice P S Kong, Majid Ezzati,[...]. Lancet 2021
5
Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.
Kasia J Lipska, Irl B Hirsch, Matthew C Riddle. JAMA 2017
Kasia J Lipska, Irl B Hirsch, Matthew C Riddle. JAMA 2017
7
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
K Horvath, K Jeitler, A Berghold, S H Ebrahim, T W Gratzer, J Plank, T Kaiser, T R Pieber, A Siebenhofer. Cochrane Database Syst Rev 2007
K Horvath, K Jeitler, A Berghold, S H Ebrahim, T W Gratzer, J Plank, T Kaiser, T R Pieber, A Siebenhofer. Cochrane Database Syst Rev 2007
4
Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia.
Medha N Munshi, Christine Slyne, Alissa R Segal, Nora Saul, Courtney Lyons, Katie Weinger. JAMA Intern Med 2016
Medha N Munshi, Christine Slyne, Alissa R Segal, Nora Saul, Courtney Lyons, Katie Weinger. JAMA Intern Med 2016
5
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet 2018
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet 2018
4
Why is there no generic insulin? Historical origins of a modern problem.
Jeremy A Greene, Kevin R Riggs. N Engl J Med 2015
Jeremy A Greene, Kevin R Riggs. N Engl J Med 2015
6
Basal insulin and cardiovascular and other outcomes in dysglycemia.
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle,[...]. N Engl J Med 2012
4
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
4
Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia.
David Beran, John S Yudkin, Maximilian de Courten. Diabetes Care 2005
David Beran, John S Yudkin, Maximilian de Courten. Diabetes Care 2005
4
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
4
Type 1 diabetes through the life span: a position statement of the American Diabetes Association.
Jane L Chiang, M Sue Kirkman, Lori M B Laffel, Anne L Peters. Diabetes Care 2014
Jane L Chiang, M Sue Kirkman, Lori M B Laffel, Anne L Peters. Diabetes Care 2014
4
Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial.
Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C Carr, Jason Mallory, Philip Home. Diabetes Care 2020
Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C Carr, Jason Mallory, Philip Home. Diabetes Care 2020
27
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.
M Peyrot, A H Barnett, L F Meneghini, P-M Schumm-Draeger. Diabet Med 2012
M Peyrot, A H Barnett, L F Meneghini, P-M Schumm-Draeger. Diabet Med 2012
4
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.
Steven E Kahn, Mark E Cooper, Stefano Del Prato. Lancet 2014
Steven E Kahn, Mark E Cooper, Stefano Del Prato. Lancet 2014
4
Total Chemical Synthesis of a Nonfibrillating Human Glycoinsulin.
Mohammed Akhter Hossain, Ryo Okamoto, John A Karas, Praveen Praveen, Mengjie Liu, Briony E Forbes, John D Wade, Yasuhiro Kajihara. J Am Chem Soc 2020
Mohammed Akhter Hossain, Ryo Okamoto, John A Karas, Praveen Praveen, Mengjie Liu, Briony E Forbes, John D Wade, Yasuhiro Kajihara. J Am Chem Soc 2020
20
Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
Olga Montvida, Jonathan Shaw, John J Atherton, Frances Stringer, Sanjoy K Paul. Diabetes Care 2018
Olga Montvida, Jonathan Shaw, John J Atherton, Frances Stringer, Sanjoy K Paul. Diabetes Care 2018
4
(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Thomas Semlitsch, Jennifer Engler, Andrea Siebenhofer, Klaus Jeitler, Andrea Berghold, Karl Horvath. Cochrane Database Syst Rev 2020
Thomas Semlitsch, Jennifer Engler, Andrea Siebenhofer, Klaus Jeitler, Andrea Berghold, Karl Horvath. Cochrane Database Syst Rev 2020
20
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Joshua A Salomon, Theo Vos, Daniel R Hogan, Michael Gagnon, Mohsen Naghavi, Ali Mokdad, Nazma Begum, Razibuzzaman Shah, Muhammad Karyana, Soewarta Kosen,[...]. Lancet 2012
Joshua A Salomon, Theo Vos, Daniel R Hogan, Michael Gagnon, Mohsen Naghavi, Ali Mokdad, Nazma Begum, Razibuzzaman Shah, Muhammad Karyana, Soewarta Kosen,[...]. Lancet 2012
2
2
Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
Jing Luo, Nazleen F Khan, Thomas Manetti, Jim Rose, Ani Kaloghlian, Balu Gadhe, Sachin H Jain, Joshua J Gagne, Aaron S Kesselheim. JAMA 2019
Jing Luo, Nazleen F Khan, Thomas Manetti, Jim Rose, Ani Kaloghlian, Balu Gadhe, Sachin H Jain, Joshua J Gagne, Aaron S Kesselheim. JAMA 2019
8
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
Kasia J Lipska, Melissa M Parker, Howard H Moffet, Elbert S Huang, Andrew J Karter. JAMA 2018
Kasia J Lipska, Melissa M Parker, Howard H Moffet, Elbert S Huang, Andrew J Karter. JAMA 2018
4
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone N Troelsen, Kajsa Kvist, Paul Norwood. JAMA 2017
Carol Wysham, Anuj Bhargava, Louis Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone N Troelsen, Kajsa Kvist, Paul Norwood. JAMA 2017
2
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Birgit Fullerton, Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Thomas Semlitsch, Andrea Berghold, Ferdinand M Gerlach. Cochrane Database Syst Rev 2018
Birgit Fullerton, Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Thomas Semlitsch, Andrea Berghold, Ferdinand M Gerlach. Cochrane Database Syst Rev 2018
9
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.
Lydia W Turner, David Nartey, Randall S Stafford, Sonal Singh, G Caleb Alexander. Diabetes Care 2014
Lydia W Turner, David Nartey, Randall S Stafford, Sonal Singh, G Caleb Alexander. Diabetes Care 2014
2
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
A Cameron, M Ewen, D Ross-Degnan, D Ball, R Laing. Lancet 2009
A Cameron, M Ewen, D Ross-Degnan, D Ball, R Laing. Lancet 2009
2
Essential medicines for universal health coverage.
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo,[...]. Lancet 2017
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo,[...]. Lancet 2017
2
Insulin patents and market exclusivities: unresolved issues--Authors' reply.
Jing Luo, Aaron S Kesselheim. Lancet Diabetes Endocrinol 2016
Jing Luo, Aaron S Kesselheim. Lancet Diabetes Endocrinol 2016
40
Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.
David Beran, Irl B Hirsch, John S Yudkin. Diabetes Care 2018
David Beran, Irl B Hirsch, John S Yudkin. Diabetes Care 2018
7
Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology.
Rui-Feng Hu, Xiao-Bo Sun. Chin J Nat Med 2017
Rui-Feng Hu, Xiao-Bo Sun. Chin J Nat Med 2017
8
Sulfonylureas and their use in clinical practice.
Daniele Sola, Luca Rossi, Gian Piero Carnevale Schianca, Pamela Maffioli, Marcello Bigliocca, Roberto Mella, Francesca Corlianò, Gian Paolo Fra, Ettore Bartoli, Giuseppe Derosa. Arch Med Sci 2015
Daniele Sola, Luca Rossi, Gian Piero Carnevale Schianca, Pamela Maffioli, Marcello Bigliocca, Roberto Mella, Francesca Corlianò, Gian Paolo Fra, Ettore Bartoli, Giuseppe Derosa. Arch Med Sci 2015
2
Understanding the role of the gut ecosystem in diabetes mellitus.
Wanping Aw, Shinji Fukuda. J Diabetes Investig 2018
Wanping Aw, Shinji Fukuda. J Diabetes Investig 2018
3
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.